RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 86 filers reported holding RAPT THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $244,995 | -7.8% | 14,741 | +3.7% | 0.00% | 0.0% |
| Q2 2023 | $265,839 | +0.7% | 14,216 | -1.2% | 0.00% | 0.0% |
| Q1 2023 | $264,112 | +7.3% | 14,393 | +15.8% | 0.00% | 0.0% |
| Q4 2022 | $246,154 | -17.1% | 12,432 | +0.7% | 0.00% | 0.0% |
| Q3 2022 | $297,000 | +33.8% | 12,344 | +1.4% | 0.00% | 0.0% |
| Q2 2022 | $222,000 | -4.7% | 12,169 | +15.0% | 0.00% | +100.0% |
| Q1 2022 | $233,000 | -44.0% | 10,580 | -6.6% | 0.00% | -50.0% |
| Q4 2021 | $416,000 | +14.9% | 11,324 | -2.9% | 0.00% | 0.0% |
| Q3 2021 | $362,000 | +13.1% | 11,662 | +15.8% | 0.00% | +100.0% |
| Q2 2021 | $320,000 | +125.4% | 10,070 | +57.5% | 0.00% | – |
| Q1 2021 | $142,000 | +12.7% | 6,395 | +0.3% | 0.00% | – |
| Q4 2020 | $126,000 | -40.3% | 6,378 | -2.8% | 0.00% | -100.0% |
| Q3 2020 | $211,000 | +8.2% | 6,560 | -2.2% | 0.00% | 0.0% |
| Q2 2020 | $195,000 | +786.4% | 6,710 | +537.8% | 0.00% | – |
| Q1 2020 | $22,000 | -18.5% | 1,052 | +8.0% | 0.00% | – |
| Q4 2019 | $27,000 | – | 974 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 2,680,621 | $53,076,296 | 17.67% |
| Euclidean Capital LLC | 432,900 | $8,571,420 | 8.02% |
| GREAT POINT PARTNERS LLC | 1,436,569 | $28,444,066 | 5.58% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 880,000 | $17,424,000 | 3.47% |
| Trustees of Columbia University in the City of New York | 73,383 | $1,453 | 3.00% |
| Cheyne Capital Management (UK) LLP | 71,828 | $1,422,194 | 2.48% |
| Deep Track Capital, LP | 1,304,940 | $25,837,812 | 1.08% |
| Ghost Tree Capital, LLC | 125,000 | $2,475,000 | 1.06% |
| Perceptive Advisors | 1,798,955 | $35,619,309 | 1.00% |
| BRAIDWELL LP | 1,000,000 | $19,800,000 | 0.66% |